A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
GlaxoSmithKline
GlaxoSmithKline
National Cancer Institute (NCI)
University of Kentucky
Asan Medical Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center